We are live on ! Find out more
RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $810M
1-Year Est. Return 30.2%
This Fund
S&P 500
This Quarter Est. Return
+5.59%
1 Year Est. Return
+30.2%
3 Year Est. Return
+116.38%
5 Year Est. Return
+153.13%
10 Year Est. Return
+962.25%
AUM
$908M
AUM Growth
+$52.9M
Cap. Flow
+$30.8M
Cap. Flow %
3.39%
Top 10 Hldgs %
29.34%
Holding
100
New
7
Increased
28
Reduced
31
Closed
12

Top Buys

Rank Stock Value
1
HBNC icon
Horizon Bancorp
HBNC
+$17.6M
2
HCA icon
HCA Healthcare
HCA
+$17.2M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$9.66M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$8.58M
5
LLY icon
Eli Lilly
LLY
+$7.22M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$24.8M
2
ARRY
Array Biopharma Inc
ARRY
+$14.8M
3
AGN
Allergan plc
AGN
+$13M
4
CI icon
Cigna
CI
+$9.95M
5
WBA
Walgreens Boots Alliance
WBA
+$9.17M

Sector Composition

Rank Sector Weight
1 Healthcare 91.04%
2 Financials 2.97%
3 Industrials 0.36%
4 Technology 0.08%
5 Energy 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACHN
76
DELISTED
Achillion Pharmaceuticals
ACHN
$745K 0.08%
277,800
– –
CVX icon
77
Chevron
CVX
$366B
$370K 0.04%
2,974
-759
-20% -$91.8K
IBM icon
78
IBM
IBM
$224B
$305K 0.03%
2,317
-257
-10% -$33.8K
BUD icon
79
AB InBev
BUD
$165B
$302K 0.03%
3,409
-379
-10% -$32.5K
F icon
80
Ford
F
$55.7B
$298K 0.03%
29,164
-3,241
-10% -$31.9K
XOM icon
81
ExxonMobil
XOM
$634B
$295K 0.03%
3,854
-2,257
-37% -$175K
DIS icon
82
Walt Disney
DIS
$181B
$291K 0.03%
2,083
-1,400
-40% -$186K
JPM icon
83
JPMorgan Chase
JPM
$950B
$276K 0.03%
2,472
-275
-10% -$30.3K
VIRX
84
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$274K 0.03%
10,778
– –
QCOM icon
85
Qualcomm
QCOM
$176B
$258K 0.03%
3,391
-3,085
-48% -$226K
WFC icon
86
Wells Fargo
WFC
$264B
$249K 0.03%
5,272
-586
-10% -$27.4K
JHG
87
DELISTED
Janus Henderson
JHG
$228K 0.03%
10,645
-1,183
-10% -$27K
MSFT icon
88
Microsoft
MSFT
$3.71T
$205K 0.02%
1,532
-1,355
-47% -$172K
ABBV icon
89
AbbVie
ABBV
$435B
– –
-60,000
Closed -$4.83M
GEN icon
90
Gen Digital
GEN
$17.5B
– –
-9,734
Closed -$224K
GOOGL icon
91
Alphabet (Google) Class A
GOOGL
$4.33T
– –
-3,560
Closed -$209K
HAL icon
92
Halliburton
HAL
$26.6B
– –
-9,221
Closed -$270K
PFE icon
93
Pfizer
PFE
$153B
– –
-5,279
Closed -$213K
WBA
94
DELISTED
Walgreens Boots Alliance
WBA
– –
-145,000
Closed -$9.17M
CMRX
95
DELISTED
Chimerix, Inc.
CMRX
– –
-68,832
Closed -$145K
FLXN
96
DELISTED
Flexion Therapeutics, Inc.
FLXN
– –
-117,265
Closed -$1.46M
AGN
97
DELISTED
Allergan plc
AGN
– –
-88,600
Closed -$13M
ARRY
98
DELISTED
Array Biopharma Inc
ARRY
– –
-607,070
Closed -$14.8M
HZNP
99
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-939,973
Closed -$24.8M
CELG
100
DELISTED
Celgene Corp
CELG
– –
-65,698
Closed -$6.2M
1 2 3
4

Similar funds

PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
RIM
Redwood Investment Management Scottsdale, Arizona $805M AUM 15.01% 1-Year Est. Return
GCM
Glendon Capital Management Santa Monica, California $805M AUM 17.91% 1-Year Est. Return
CL
CVFG LLC Shelbyville, Indiana $804M AUM 27.61% 1-Year Est. Return

Rhenman & Partners Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, Rhenman & Partners Asset Management held 100 positions worth $908M, up 6.2% from $855M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Rhenman & Partners Asset Management deployed $30.8M of net new capital in Q2 2019, opening 7 new positions and adding to 28 existing holdings. Its largest new stake was Horizon Bancorp: 1,087,656 shares worth $26.2M.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, down from 94% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Cigna, an estimated $9.95M trimmed.

  • Rhenman & Partners Asset Management's largest Q2 2019 buy was Horizon Bancorp: 1,087,656 shares worth $26.2M.
  • Rhenman & Partners Asset Management added most to Regeneron Pharmaceuticals in Q2 2019, an estimated $9.66M increase.
  • Rhenman & Partners Asset Management's biggest Q2 2019 reduction was Cigna, cutting an estimated $9.95M.
  • Rhenman & Partners Asset Management fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2019, selling an estimated $24.8M.
  • Rhenman & Partners Asset Management's ten largest holdings make up 29% of its $908M portfolio in Q2 2019.
  • Rhenman & Partners Asset Management opened 7 new positions and closed 12 in Q2 2019.
  • Rhenman & Partners Asset Management's portfolio value rose 6.2% quarter-over-quarter to $908M.

Based on Rhenman & Partners Asset Management's 13F filing for Q2 2019, filed 22 Jul 2019.